SpringerLink
Log in

Diagnosis and Management of Pancreatic Cystic Neoplasms

  • Pancreas (V Chandrasekhara, Section Editor)
  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Opinion statement

Pancreatic cystic neoplasms (PCNs) are being diagnosed with increasing frequency. PCNs have diverse presentations, natural history, and biological behavior. Obtaining an accurate diagnosis of the type of cyst and assessing the potential for malignancy are crucial in determining the appropriate management strategy. Cross-sectional imaging with computed tomography (CT) or magnetic resonance imaging (MRI), at experienced centers, is effective in defining the type of cyst as well as identifying high-risk features. Endoscopic ultrasound with fine-needle aspiration (EUS-FNA) and cyst fluid analysis can categorize and risk-stratify cysts and is the test of choice in selected patients. However, there is currently no “perfect” test and studies have demonstrated substantial misdiagnosis and over-treatment of benign cysts using standard clinical, imaging, and cyst fluid analyses. Patients with symptomatic cysts or cysts with high-risk features suggestive of malignancy should be considered for surgical resection. Patients with low-risk PCNs can be placed in surveillance protocols with interval imaging. Various gastrointestinal societies have put forth evidence- or consensus-based guidelines that provide a framework for management of PCNs. However, the management can be complex and should ideally be planned in a multidisciplinary fashion by experienced specialists. Recent investigations using molecular markers to risk-stratify cysts offer promise in the future for an effective and accurate management strategy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Brazil)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Laffan TA, Horton KM, Klein AP, Berlanstein B, Siegelman SS, Kawamoto S, et al. Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol. 2008;191(3):802–7.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Lee KS, Sekhar A, Rofsky NM, Pedrosa I. Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am J Gastroenterol. 2010;105(9):2079–84.

    Article  PubMed  Google Scholar 

  3. Valsangkar NP, Morales-Oyarvide V, Thayer SP, Ferrone CR, Wargo JA, Warshaw AL, et al. 851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital. Surgery. 2012;152(3 Suppl 1):S4–12.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Gaujoux S, Brennan MF, Gonen M, D'Angelica MI, DeMatteo R, Fong Y, et al. Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15-year time period. J Am Coll Surg. 2011;212(4):590–600.

    Article  PubMed  Google Scholar 

  5. D'Angelica M, Brennan MF, Suriawinata AA, Klimstra D, Conlon KC. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann Surg. 2004;239(3):400–8.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6(1–2):17–32.

    Article  PubMed  Google Scholar 

  7. Abdeljawad K, Vemulapalli KC, Schmidt CM, Dewitt J, Sherman S, Imperiale TF, et al. Prevalence of malignancy in patients with pure main duct intraductal papillary mucinous neoplasms. Gastrointest Endosc. 2014;79(4):623–9.

    Article  PubMed  Google Scholar 

  8. Furukawa T, Hatori T, Fujita I, Yamamoto M, Kobayashi M, Ohike N, et al. Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut. 2011;60(4):509–16.

    Article  PubMed  Google Scholar 

  9. Park WG, Mascarenhas R, Palaez-Luna M, Smyrk TC, O'Kane D, Clain JE, et al. Diagnostic performance of cyst fluid carcinoembryonic antigen and amylase in histologically confirmed pancreatic cysts. Pancreas. 2011;40(1):42–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Reddy RP, Smyrk TC, Zapiach M, Levy MJ, Pearson RK, Clain JE, et al. Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol. 2004;2(11):1026–31.

    Article  PubMed  Google Scholar 

  11. Brugge WR. Diagnosis and management of cystic lesions of the pancreas. J Gastrointest Oncol. 2015;6(4):375–88.

    PubMed  PubMed Central  Google Scholar 

  12. Zamboni G, Scarpa A, Bogina G, Iacono C, Bassi C, Talamini G, et al. Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol. 1999;23(4):410–22.

    Article  CAS  PubMed  Google Scholar 

  13. Compagno J, Oertel JE. Microcystic adenomas of the pancreas (glycogen-rich cystadenomas): a clinicopathologic study of 34 cases. Am J Clin Pathol. 1978;69(3):289–98.

    Article  CAS  PubMed  Google Scholar 

  14. Wu J, Jiao Y, Dal Molin M, Maitra A, de Wilde RF, Wood LD, et al. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A. 2011;108(52):21188–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. El-Hayek KM, Brown N, O'Rourke C, Falk G, Morris-Stiff G, Walsh RM. Rate of growth of pancreatic serous cystadenoma as an indication for resection. Surgery. 2013;154(4):794–802.

    Article  PubMed  Google Scholar 

  16. Lee SE, Jang JY, Hwang DW, Park KW, Kim SW. Clinical features and outcome of solid pseudopapillary neoplasm: differences between adults and children. Arch Surg. 2008;143(12):1218–21.

    Article  PubMed  Google Scholar 

  17. Kim MJ, Choi DW, Choi SH, Heo JS, Sung JY. Surgical treatment of solid pseudopapillary neoplasms of the pancreas and risk factors for malignancy. Br J Surg. 2014;101(10):1266–71.

    Article  CAS  PubMed  Google Scholar 

  18. Law JK, Ahmed A, Singh VK, Akshintala VS, Olson MT, Raman SP, et al. A systematic review of solid-pseudopapillary neoplasms: are these rare lesions? Pancreas. 2014;43(3):331–7.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Birnbaum DJ, Gaujoux S, Berbis J, Dokmak S, Hammel P, Vullierme MP, et al. Surgery for pancreatic neoplasms: how accurate are our surgical indications? Surgery. 2017; https://doi.org/10.1016/j.surg.2017.01.015.

  20. Grant RC, Selander I, Connor AA, Selvarajah S, Borgida A, Briollais L, et al. Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer. Gastroenterology. 2015;148(3):556–64.

    Article  CAS  PubMed  Google Scholar 

  21. Lennon AM, Manos LL, Hruban RH, Ali SZ, Fishman EK, Kamel IR, et al. Role of a multidisciplinary clinic in the management of patients with pancreatic cysts: a single-center cohort study. Ann Surg Oncol. 2014;21(11):3668–74.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Lee HJ, Kim MJ, Choi JY, Hong HS, Kim KA. Relative accuracy of CT and MRI in the differentiation of benign from malignant pancreatic cystic lesions. Clin Radiol. 2011;66(4):315–21.

    Article  PubMed  Google Scholar 

  23. Visser BC, Yeh BM, Qayyum A, Way LW, McCulloch CE, Coakley FV. Characterization of cystic pancreatic masses: relative accuracy of CT and MRI. AJR Am J Roentgenol. 2007;189(3):648–56.

    Article  PubMed  Google Scholar 

  24. •• Scheiman JM, Hwang JH, Moayyedi P. American gastroenterological association technical review on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015;148(4):824–48 e22. The 2015 AGA guidelines are the most comprehensive review of available data for outcomes in PCNs.

    Article  PubMed  Google Scholar 

  25. Khashab MA, Kim K, Lennon AM, Shin EJ, Tignor AS, Amateau SK, et al. Should we do EUS/FNA on patients with pancreatic cysts? The incremental diagnostic yield of EUS over CT/MRI for prediction of cystic neoplasms. Pancreas. 2013;42(4):717–21.

    Article  PubMed  Google Scholar 

  26. Yoon WJ, Brugge WR. The safety of endoscopic ultrasound-guided fine-needle aspiration of pancreatic cystic lesions. Endosc Ultrasound. 2015;4(4):289–92.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Konda VJ, Meining A, Jamil LH, Giovannini M, Hwang JH, Wallace MB, et al. A pilot study of in vivo identification of pancreatic cystic neoplasms with needle-based confocal laser endomicroscopy under endosonographic guidance. Endoscopy. 2013;45(12):1006–13.

    Article  PubMed  Google Scholar 

  28. Walsh RM, Henderson JM, Vogt DP, Baker ME, O'Malley CM Jr, Herts B, et al. Prospective preoperative determination of mucinous pancreatic cystic neoplasms. Surgery. 2002;132(4):628–34.

    Article  PubMed  Google Scholar 

  29. Thosani N, Thosani S, Qiao W, Fleming JB, Bhutani MS, Guha S. Role of EUS-FNA-based cytology in the diagnosis of mucinous pancreatic cystic lesions: a systematic review and meta-analysis. Dig Dis Sci. 2010;55(10):2756–66.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Grutzmann R, Niedergethmann M, Pilarsky C, Kloppel G, Saeger HD. Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment. Oncologist. 2010;15(12):1294–309.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Pitman MB, Yaeger KA, Brugge WR, Mino-Kenudson M. Prospective analysis of atypical epithelial cells as a high-risk cytologic feature for malignancy in pancreatic cysts. Cancer Cytopathol. 2013;121(1):29–36.

    Article  PubMed  Google Scholar 

  32. Genevay M, Mino-Kenudson M, Yaeger K, Konstantinidis IT, Ferrone CR, Thayer S, et al. Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts. Ann Surg. 2011;254(6):977–83.

    Article  PubMed  Google Scholar 

  33. Pitman MB, Michaels PJ, Deshpande V, Brugge WR, Bounds BC. Cytological and cyst fluid analysis of small (< or =3 cm) branch duct intraductal papillary mucinous neoplasms adds value to patient management decisions. Pancreatology. 2008;8(3):277–84.

    Article  PubMed  Google Scholar 

  34. •• Brugge WR, Lewandrowski K, Lee-Lewandrowski E, Centeno BA, Szydlo T, Regan S, et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology. 2004;126(5):1330–6. This is the landmark study that evaluated the role of CEA in the diagnosis of mucinous PCNs.

    Article  PubMed  Google Scholar 

  35. Cizginer S, Turner BG, Bilge AR, Karaca C, Pitman MB, Brugge WR. Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. Pancreas. 2011;40(7):1024–8.

    Article  CAS  PubMed  Google Scholar 

  36. Al-Haddad M, Gill KR, Raimondo M, Woodward TA, Krishna M, Crook JE, et al. Safety and efficacy of cytology brushings versus standard fine-needle aspiration in evaluating cystic pancreatic lesions: a controlled study. Endoscopy. 2010;42(2):127–32.

    Article  CAS  PubMed  Google Scholar 

  37. • Khalid A, Zahid M, Finkelstein SD, LeBlanc JK, Kaushik N, Ahmad N, et al. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc. 2009;69(6):1095–102. The seminal study that introduced the value of molecular markers in the workup of PCNs.

    Article  PubMed  Google Scholar 

  38. Nikiforova MN, Khalid A, Fasanella KE, McGrath KM, Brand RE, Chennat JS, et al. Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts. Mod Pathol. 2013;26(11):1478–87.

    Article  CAS  PubMed  Google Scholar 

  39. Singhi AD, Nikiforova MN, Fasanella KE, McGrath KM, Pai RK, Ohori NP, et al. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts. Clin Cancer Res. 2014;20(16):4381–9.

    Article  CAS  PubMed  Google Scholar 

  40. Wu J, Matthaei H, Maitra A, Dal Molin M, Wood LD, Eshleman JR, et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med. 2011;3(92):92ra66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Matthaei H, Wylie D, Lloyd MB, Dal Molin M, Kemppainen J, Mayo SC, et al. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res. 2012;18(17):4713–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Ryu JK, Matthaei H, Dal Molin M, Hong SM, Canto MI, Schulick RD, et al. Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma. Pancreatology. 2011;11(3):343–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Habbe N, Koorstra JB, Mendell JT, Offerhaus GJ, Ryu JK, Feldmann G, et al. MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther. 2009;8(4):340–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. •• Tanaka M, Fernandez-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12(3):183–97. The updated version of the Sendai guidelines.

    Article  PubMed  Google Scholar 

  45. Maguchi H, Tanno S. Natural history and malignant transformation of branch duct IPMN. In: Tanaka M, editor. Intraductal papillary mucinous neoplasm of the pancreas. Tokyo: Springer Japan; 2014. p. 19–26.

    Chapter  Google Scholar 

  46. • Vege SS, Ziring B, Jain R, Moayyedi P, Clinical Guidelines C, American Gastroenterology A. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015;148(4):819–22. The complementary paper to the AGA guidelines.

    Article  PubMed  Google Scholar 

  47. Tanno S, Nakano Y, Koizumi K, Sugiyama Y, Nakamura K, Sasajima J, et al. Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms. Pancreas. 2010;39(1):36–40.

    Article  PubMed  Google Scholar 

  48. Malleo G, Marchegiani G, Borin A, Capelli P, Accordini F, Butturini G, et al. Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm. Ann Surg. 2015;261(5):984–90.

    Article  PubMed  Google Scholar 

  49. Khannoussi W, Vullierme MP, Rebours V, Maire F, Hentic O, Aubert A, et al. The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology. 2012;12(3):198–202.

    Article  PubMed  Google Scholar 

  50. Sighinolfi M, Quan SY, Lee Y, Ibaseta A, Pham K, Dua MM, et al. Fukuoka and AGA criteria have superior diagnostic accuracy for advanced cystic neoplasms than Sendai criteria. Dig Dis Sci. 2017;62(3):626–32.

    Article  PubMed  Google Scholar 

  51. Ma GK, Goldberg DS, Thiruvengadam N, Chandrasekhara V, Kochman ML, Ginsberg GG, et al. Comparing American Gastroenterological Association pancreatic cyst management guidelines with Fukuoka consensus guidelines as predictors of advanced neoplasia in patients with suspected pancreatic cystic neoplasms. J Am Coll Surg. 2016;223(5):729–37.

    Article  PubMed  Google Scholar 

  52. Committee ASoP, Muthusamy VR, Chandrasekhara V, Acosta RD, Bruining DH, Chathadi KV, et al. The role of endoscopy in the diagnosis and treatment of cystic pancreatic neoplasms. Gastrointest Endosc. 2016;84(1):1–9.

    Article  Google Scholar 

  53. DeWitt J, McGreevy K, Schmidt CM, Brugge WR. EUS-guided ethanol versus saline solution lavage for pancreatic cysts: a randomized, double-blind study. Gastrointest Endosc. 2009;70(4):710–23.

    Article  PubMed  Google Scholar 

  54. Oh HC, Seo DW, Lee TY, Kim JY, Lee SS, Lee SK, et al. New treatment for cystic tumors of the pancreas: EUS-guided ethanol lavage with paclitaxel injection. Gastrointest Endosc. 2008;67(4):636–42.

    Article  PubMed  Google Scholar 

  55. Oh HC, Seo DW, Song TJ, Moon SH, Park DH, Soo Lee S, et al. Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts. Gastroenterology. 2011;140(1):172–9.

    Article  CAS  PubMed  Google Scholar 

  56. Oh HC, Brugge WR. EUS-guided pancreatic cyst ablation: a critical review (with video). Gastrointest Endosc. 2013;77(4):526–33.

    Article  PubMed  Google Scholar 

  57. DiMaio CJ, DeWitt JM, Brugge WR. Ablation of pancreatic cystic lesions: the use of multiple endoscopic ultrasound-guided ethanol lavage sessions. Pancreas. 2011;40(5):664–8.

    Article  PubMed  Google Scholar 

  58. Oh HC, Seo DW, Kim SC. Portal vein thrombosis after EUS-guided pancreatic cyst ablation. Dig Dis Sci. 2012;57(7):1965–7.

    Article  PubMed  Google Scholar 

  59. Crippa S, Salvia R, Warshaw AL, Dominguez I, Bassi C, Falconi M, et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg. 2008;247(4):571–9.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Xourafas D, Tavakkoli A, Clancy TE, Ashley SW. Noninvasive intraductal papillary mucinous neoplasms and mucinous cystic neoplasms: recurrence rates and postoperative imaging follow-up. Surgery. 2015;157(3):473–83.

    Article  PubMed  Google Scholar 

  61. Tien YW, Hu RH, Hung JS, Wang HP, Lee PH. Noninvasive pancreatic cystic neoplasms can be safely and effectively treated by limited pancreatectomy. Ann Surg Oncol. 2008;15(1):193–8.

    Article  PubMed  Google Scholar 

  62. Marchegiani G, Mino-Kenudson M, Ferrone CR, Morales-Oyarvide V, Warshaw AL, Lillemoe KD, et al. Patterns of recurrence after resection of IPMN: who, when, and how? Ann Surg. 2015;262(6):1108–14.

    Article  PubMed  Google Scholar 

  63. Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239(6):788–99.

    Article  PubMed  PubMed Central  Google Scholar 

  64. White R, D'Angelica M, Katabi N, Tang L, Klimstra D, Fong Y, et al. Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. J Am Coll Surg. 2007;204(5):987–95.

    Article  PubMed  Google Scholar 

  65. Kang MJ, Jang JY, Lee KB, Chang YR, Kwon W, Kim SW. Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: implications for postoperative surveillance. Ann Surg. 2014;260(2):356–63.

    Article  PubMed  Google Scholar 

  66. Winner M, Epelboym I, Remotti H, Lee JL, Schrope BA, Chabot JA, et al. Predictors of recurrence in intraductal papillary mucinous neoplasm: experience with 183 pancreatic resections. J Gastrointest Surg. 2013;17(9):1618–26.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA

    Malcolm Kearns MD

  2. Division of Gastroenterology, Department of Medicine, Hospital of the University of Pennsylvania, 3400 Civic Center Blvd, PCAM 7 South, Philadelphia, PA, 1910, USA

    Nuzhat A. Ahmad MD

Authors
  1. Malcolm Kearns MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nuzhat A. Ahmad MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nuzhat A. Ahmad MD.

Ethics declarations

Conflict of Interest

Malcolm Kearns declares that he has no conflict of interest. Nuzhat A. Ahmad declares that she has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Pancreas

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kearns, M., Ahmad, N.A. Diagnosis and Management of Pancreatic Cystic Neoplasms. Curr Treat Options Gastro 15, 587–602 (2017). https://doi.org/10.1007/s11938-017-0162-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-017-0162-y

Keywords

Search

Navigation